AbbVie Inc. (ABBV) Q2 2026 Earnings Call Transcript

SA Transcripts 161.41K Followers Follow AbbVie Inc. ( ABBV ) Q2 2026 Earnings Call July 31, 2026 9:00 AM EDT Company Participants Elizabeth Shea - Senior Vice President of Investor Relations Robert Michael - CEO & Chairman of the Board Jeffrey Stewart - Executive VP & Chief Commercial Officer Roopal Thakkar - Executive VP of Research & Development and Chief Scientific Officer Scott Reents - Executive VP & CFO Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Carter Gould - Cantor Fitzgerald & Co., Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Michael Yee - UBS Investment Bank, Research Division Mohit Bansal - Wells Fargo Securities, LLC, Research Division Asad Haider - Goldman Sachs Group, Inc., Research Division David Amsellem - Piper Sandler & Co., Research Division Luisa Hector - Joh. Berenberg, Gossler & Co. KG, Research Division Matthew Phipps - William Blair & Company L.L.C., Research Division Louise Chen - Scotiabank Global Banking and Markets, Research Division Evan Seigerman - BMO Capital Markets Equity Research Presentation Operator Good morning, and thank you for standing by. Welcome to the AbbVie Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would now like to introduce Ms. Liz Shea, Senior Vice President, Investor Relations. Elizabeth Shea Senior Vice President of Investor Relations Good morning, and thanks for joining us. Also on the call with me today are Rob Michael, Chairman and Chief Executive Officer; Jeff Stewart, Executive Vice President, Chief Commercial Officer; Roopal Thakkar, Executive Vice President, Research and Development, Chief Scientific Officer; and Scott Reents, Executive Vice President, Chief Financial Officer. Before we get started, I'll note that some statements we make today may be considered forward-looking statements based on our current expectations. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results